UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Intranasal respiratory syncytial virus vaccine attenuated by codon-pair deoptimization of seven open reading frames is genetically stable and elicits mucosal and systemic immunity and protection against challenge virus replication in hamsters

PLoS pathogens, 2024-05, Vol.20 (5), p.e1012198-e1012198

2024

Volltextzugriff (PDF)

Generation of novel respiratory syncytial virus vaccine candidate antigens that can induce high levels of prefusion-specific antibodies

Journal of bioscience and bioengineering, 2024-08, Vol.138 (2), p.127-136

2024

Volltextzugriff (PDF)

Mucosal delivery of a prefusogenic-F, glycoprotein, and matrix proteins-based virus-like particle respiratory syncytial virus vaccine induces protective immunity as evidenced by challenge studies in mice

Virology (New York, N.Y.), 2024-10, Vol.598, p.110194, Article 110194

2024

Volltextzugriff (PDF)

The tricky second album: Licensure of an mRNA vaccine for respiratory syncytial virus

Molecular therapy, 2024-08, Vol.32 (8), p.2428-2428

Tregoning, John S.

2024

Volltextzugriff (PDF)

Development of innate and adaptive immunity to RSV in young children

Cellular immunology, 2024-05, Vol.399-400, p.104824, Article 104824

2024

Volltextzugriff (PDF)

Efficacy of a virus-vectored vaccine against human and bovine respiratory syncytial virus infections

Science translational medicine, 2015-08, Vol.7 (300), p.300ra127

2015

Volltextzugriff (PDF)

Enhanced susceptibility of pediatric airway epithelium to respiratory syncytial virus infection

The Journal of clinical investigation, 2024-11, Vol.134 (21)

2024

Volltextzugriff (PDF)

Chimeric bovine/human parainfluenza virus type 3 expressing respiratory syncytial virus (RSV) F glycoprotein: effect of insert position on expression, replication, immunogenicity, stability, and protection against RSV infection

Journal of virology, 2014-04, Vol.88 (8), p.4237-4250

2014

Volltextzugriff (PDF)

Immunological Lessons from Respiratory Syncytial Virus Vaccine Development

Immunity (Cambridge, Mass.), 2019-09, Vol.51 (3), p.429-442

2019

Volltextzugriff (PDF)

Respiratory syncytial virus infection and novel interventions

Nature reviews. Microbiology, 2023-11, Vol.21 (11), p.734-749

2023

Volltextzugriff (PDF)

Formulation of the respiratory syncytial virus fusion protein with a polymer-based combination adjuvant promotes transient and local innate immune responses and leads to improved adaptive immunity

Vaccine, 2016-09, Vol.34 (42), p.5114-5124

2016

Volltextzugriff (PDF)

Prefusion F Protein–Based Respiratory Syncytial Virus Immunization in Pregnancy

The New England journal of medicine, 2022-04, Vol.386 (17), p.1615-1626

2022

Volltextzugriff (PDF)

A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanism

Nature communications, 2015-09, Vol.6 (1), p.8143-8143, Article 8143

2015

Volltextzugriff (PDF)

RNA-RNA interactions between respiratory syncytial virus and miR-26 and miR-27 are associated with regulation of cell cycle and antiviral immunity

Nucleic acids research, 2024-05, Vol.52 (9), p.4872-4888

2024

Volltextzugriff (PDF)

Viral N 6 -methyladenosine upregulates replication and pathogenesis of human respiratory syncytial virus

Nature communications, 2019-10, Vol.10 (1), p.4595-18

2019

Volltextzugriff (PDF)

Vaccine safety and efficacy evaluation of a recombinant bovine respiratory syncytial virus (BRSV) with deletion of the SH gene and subunit vaccines based on recombinant human RSV proteins: N-nanorings, P and M2-1, in calves with maternal antibodies

PloS one, 2014, Vol.9 (6), p.e100392

2014

Volltextzugriff (PDF)

The race to make vaccines for a dangerous respiratory virus

Nature (London), 2021-12, Vol.600 (7889), p.379-380

Powell, Kendall

2021

Volltextzugriff (PDF)

Immunology of bovine respiratory syncytial virus in calves

Molecular immunology, 2015-07, Vol.66 (1), p.48-56

2015

Volltextzugriff (PDF)

Recombinant bovine respiratory syncytial virus with deletion of the SH gene induces increased apoptosis and pro-inflammatory cytokines in vitro, and is attenuated and induces protective immunity in calves

Journal of general virology, 2014-06, Vol.95 (Pt 6), p.1244-1254

2014

Volltextzugriff (PDF)

Chimpanzee adenovirus- and MVA-vectored respiratory syncytial virus vaccine is safe and immunogenic in adults

Science translational medicine, 2015-08, Vol.7 (300), p.300ra126

2015

Volltextzugriff (PDF)

Novel antigens for RSV vaccines

Current opinion in immunology, 2015-08, Vol.35, p.30-38

2015

Volltextzugriff (PDF)

Brief History and Characterization of Enhanced Respiratory Syncytial Virus Disease

Clinical and vaccine immunology, 2016-03, Vol.23 (3), p.189-195

2016

Volltextzugriff (PDF)

Live-Attenuated Respiratory Syncytial Virus Vaccine With M2-2 Deletion and With Small Hydrophobic Noncoding Region Is Highly Immunogenic in Children

The Journal of infectious diseases, 2020-06, Vol.221 (12), p.2050-2059

2020

Volltextzugriff (PDF)

Long-Term SARS-CoV-2 Findings Related to Persisting Viral Antigen and Inflammation Resemble Those Reported for Influenza Virus and Respiratory Syncytial Virus

Viruses, 2024-09, Vol.16 (9), p.1353

Roberts, Jr, Norbert J

2024

Volltextzugriff (PDF)

The role of Th17 and Treg responses in the pathogenesis of RSV infection

Pediatric research, 2015-11, Vol.78 (5), p.483-491

2015

Volltextzugriff (PDF)

1 – 25 von 7.246

Suche als RSS-Feed

Aktive Filter

KollektionSpringerLINK Contemporary (Konsortium Baden-Württemberg)

SpracheTschechisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(6.757)
Mit Volltextzugriff
(5.502)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(6.307)
Life Sciences & Biomedicine
(5.982)
Humans
(5.023)
Respiratory Syncytial Virus
(4.503)
Immunology
(3.803)
Animals
(2.690)
Female
(2.391)
Infectious Diseases
(2.216)
Infant
(2.126)
Respiratory Syncytial Viruses - Immunology
(2.083)
Respiratory Syncytial Virus Infections - Immunology
(1.943)
Biological And Medical Sciences
(1.886)
Microbiology
(1.787)
Male
(1.688)
Virology
(1.566)
Viruses
(1.555)
Infections
(1.379)
Mice
(1.341)
Child, Preschool
(1.248)
Medical Sciences
(1.246)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(6.512)
EZB Electronic Journals Library
(4.505)
IngentaConnect Journals
(3.183)
Journals@Ovid Complete
(3.008)
Publisher or Other Site
(2.299)
IngentaConnect Journals
(1.624)
Elsevier ScienceDirect Journals Complete
(1.441)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(1.273)
Oxford Journals Online Current
(867)
Wiley Online Library Journals
(800)
Jstor Complete Legacy
(781)
Oxford Journals 2020 Medicine
(771)
Wiley Online Library Full Collection 2018
(606)
Nature
(247)
Taylor & Francis Journals
(239)
Taylor & Francis
(223)
Taylor & Francis Online
(190)
Nexis Uni
(188)
Springer Nature - Complete Springer Journals
(154)
BMJ Journals
(105)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(16)
... seit 90 Tagen
(64)

Menü

Weitere Dienste

Einstellungen

Intranasal respiratory syncytial virus vaccine attenuated by codon-pair deoptimization of seven open reading frames is genetically stable and elicits mucosal and systemic immunity and protection against challenge virus replication in hamsters

Generation of novel respiratory syncytial virus vaccine candidate antigens that can induce high levels of prefusion-specific antibodies

Mucosal delivery of a prefusogenic-F, glycoprotein, and matrix proteins-based virus-like particle respiratory syncytial virus vaccine induces protective immunity as evidenced by challenge studies in mice

The tricky second album: Licensure of an mRNA vaccine for respiratory syncytial virus

Development of innate and adaptive immunity to RSV in young children

Efficacy of a virus-vectored vaccine against human and bovine respiratory syncytial virus infections

Enhanced susceptibility of pediatric airway epithelium to respiratory syncytial virus infection

Chimeric bovine/human parainfluenza virus type 3 expressing respiratory syncytial virus (RSV) F glycoprotein: effect of insert position on expression, replication, immunogenicity, stability, and protection against RSV infection

Immunological Lessons from Respiratory Syncytial Virus Vaccine Development

Respiratory syncytial virus infection and novel interventions

Formulation of the respiratory syncytial virus fusion protein with a polymer-based combination adjuvant promotes transient and local innate immune responses and leads to improved adaptive immunity

Prefusion F Protein–Based Respiratory Syncytial Virus Immunization in Pregnancy

A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanism

RNA-RNA interactions between respiratory syncytial virus and miR-26 and miR-27 are associated with regulation of cell cycle and antiviral immunity

Viral N 6 -methyladenosine upregulates replication and pathogenesis of human respiratory syncytial virus

Vaccine safety and efficacy evaluation of a recombinant bovine respiratory syncytial virus (BRSV) with deletion of the SH gene and subunit vaccines based on recombinant human RSV proteins: N-nanorings, P and M2-1, in calves with maternal antibodies

The race to make vaccines for a dangerous respiratory virus

Immunology of bovine respiratory syncytial virus in calves

Recombinant bovine respiratory syncytial virus with deletion of the SH gene induces increased apoptosis and pro-inflammatory cytokines in vitro, and is attenuated and induces protective immunity in calves

Chimpanzee adenovirus- and MVA-vectored respiratory syncytial virus vaccine is safe and immunogenic in adults

Novel antigens for RSV vaccines

Brief History and Characterization of Enhanced Respiratory Syncytial Virus Disease

Live-Attenuated Respiratory Syncytial Virus Vaccine With M2-2 Deletion and With Small Hydrophobic Noncoding Region Is Highly Immunogenic in Children

Long-Term SARS-CoV-2 Findings Related to Persisting Viral Antigen and Inflammation Resemble Those Reported for Influenza Virus and Respiratory Syncytial Virus

The role of Th17 and Treg responses in the pathogenesis of RSV infection

Aktive Filter

Suchergebnisse filtern